Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study

Children With Neurodevelopmental Disorders Clinical Trial

Official title:

Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05443763
• Other study ID #: 2090791
• Status: Completed
• Phase: N/A
• Start date: May 23, 2022
• Est. completion date: September 1, 2022

Study information

• Verified date: June 2022
• Source: University of Missouri-Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program.

Description:

The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program. Research questions include: 1.) What are the effects of an intensive program on postural control and functional mobility for children with neurodevelopmental disorders? 2.) What are the effects of an intensive therapy program on dual tasking for children with neurodevelopmental disorders? 3.) What are the perceptions of caregivers of a multidisciplinary intensive therapy program for their children with neurodevelopmental disorders? Data will be gathered before and after the intensive program as part of usual care and ambulatory children will be further assessed in the motion analysis lab. Caregivers will complete a questionnaire about satisfaction with services and also a 4 question open-ended question survey about their experience with intensive therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: September 1, 2022
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years to 17 Years

Eligibility

Inclusion Criteria:

• Children receiving therapy through Children's Therapy Center's Tiger Intensive Program and their caregivers from May 23, 2022, to Aug 19, 2022.

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Children With Neurodevelopmental Disorders
• Neurodevelopmental Disorders

Intervention

Other:
• An interdisciplinary intensive therapy program
Children will receive physical, occupation, and/or speech therapy 1-3 hours/day each for 4-5 days/week x 4 weeks.

Locations

Country	Name	City	State
United States	Children's Therapy Center--MU Healthcare	Columbia	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Instrumented Gait Analysis	3D gait analysis in gait lab	before intensive therapy episode of care, approximately 4 weeks
Primary	Instrumented Gait Analysis	3D gait analysis in gait lab	after intensive therapy episode of care, approximately 4 weeks
Primary	Center of pressure measure	COP measure during balance task	after intensive therapy episode of care, approximately 4 weeks
Primary	Center of pressure measure	COP measure during balance task	before intensive therapy episode of care, approximately 4 weeks
Primary	Measures of processes of care (MOPC)	Questionnaire to assess satisfaction with therapy services	after intensive therapy episode of care, an average of 4 weeks
Primary	Timed up and go	TUG assessment--timed assessment including standing from a chair, walking a distance and returning to the chair	before intensive therapy episode of care, an average of 4 weeks
Primary	Timed up and go	TUG assessment--timed assessment including standing from a chair, walking a distance and returning to the chair	fter intensive therapy episode of care, an average of 4 weeks
Primary	Modified Clinical Test of Sensory Integration and Balance	mCISIB--balance test in 4 conditions	after intensive therapy episode of care, an average of 4 weeks
Primary	Modified Clinical Test of Sensory Integration and Balance	mCISIB--balance test in 4 conditions	before intensive therapy episode of care, an average of 4 weeks
Primary	Pediatric Balance Scale	PBS-balance test	before intensive therapy episode of care, an average of 4 weeks
Primary	Pediatric Balance Scale	PBS-balance test	after intensive therapy episode of care, an average of 4 weeks
Primary	Functional Gait Assessment (FGA)	Assesses functional gait performance	before intensive therapy episode of care, an average of 4 weeks
Primary	Functional Gait Assessment (FGA)	Assesses functional gait performance	after intensive therapy episode of care, an average of 4 weeks
Primary	Segmental Assessment of Trunk Control (SATCo)	Assessment of trunk control	before intensive therapy episode of care, an average of 4 weeks
Primary	Segmental Assessment of Trunk Control (SATCo)	Assessment of trunk control	after intensive therapy episode of care, an average of 4 weeks
Primary	Survey	4 open-ended questions about caregiver/child experience with intensive therapy program	after intensive therapy episode of care, an average of 4 weeks